SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063005
Filing Date
2023-11-13
Accepted
2023-11-13 16:25:30
Documents
80
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eftr-20230930.htm   iXBRL 10-Q 2288983
2 EX-31.1 eftr-ex31_1.htm EX-31.1 18392
3 EX-31.2 eftr-ex31_2.htm EX-31.2 18349
4 EX-32.1 eftr-ex32_1.htm EX-32.1 10210
5 EX-32.2 eftr-ex32_2.htm EX-32.2 10177
  Complete submission text file 0000950170-23-063005.txt   10034428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eftr-20230930_lab.xml EX-101.LAB 632177
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eftr-20230930_cal.xml EX-101.CAL 41513
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eftr-20230930_pre.xml EX-101.PRE 513918
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eftr-20230930_def.xml EX-101.DEF 370544
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eftr-20230930.xsd EX-101.SCH 87594
74 EXTRACTED XBRL INSTANCE DOCUMENT eftr-20230930_htm.xml XML 1795745
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39866 | Film No.: 231399187
SIC: 2834 Pharmaceutical Preparations